8-K: Scilex Announces $120M Datavault AI Infrastructure Deal

Scilex Holding Company has entered a binding term sheet to invest $120 million in Datavault AI for a revenue-sharing infrastructure partnership.

Summary

• Scilex Holding Company signed a binding term sheet with Datavault AI Inc. on April 26, 2026.
• The company plans to contribute $120 million in cash to fund the deployment of a quantum-ready GPU network across 100 U.S. cities.
• Scilex will receive a tiered revenue share: 30% of gross network revenues until $250 million is recovered, 15% until $1.2 billion is reached, and 5% thereafter for the lifetime of the GPUs.
• The upfront payment is expected to be paid in multiple closings, concluding by December 31, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral-to-speculative development; while the revenue potential is high, the shift into unrelated AI infrastructure introduces significant execution and capital risks.

Positives

• Potential for significant long-term revenue participation reaching up to $1.2 billion plus ongoing tail revenue.
• Strategic diversification into high-growth AI infrastructure and quantum-ready computing.

Negatives

• Significant capital outlay of $120 million, which may impact liquidity.
• The transaction is subject to definitive agreements and customary closing conditions, with no guarantee of completion.

Risks

• Execution risk regarding the deployment of GPU infrastructure across 100 cities.
• Dependency on Datavault AI's operational success and ability to generate sufficient gross revenues.
• Potential for costly litigation or disputes if the definitive agreement is not finalized.
• Market conditions and regulatory hurdles could prevent the consummation of the transaction.

Future Outlook

The company intends to finalize definitive transaction documents and deploy GPU infrastructure across 100 U.S. cities by year-end 2026, contingent on successful negotiations and operational milestones.

Management Comments

• The transaction remains subject to further negotiation, modification, and board approval.

Industry Context

StockSavvy.ai notes that this move represents a pivot for a pharmaceutical-focused company into the capital-intensive AI infrastructure sector, a trend increasingly seen as companies seek to leverage high-margin tech assets to diversify revenue streams.

Comparison to Industry Standards

• The revenue-sharing model is common in infrastructure financing but carries higher execution risk than traditional pharmaceutical R&D investments.
• The $120 million investment is substantial relative to typical mid-cap biotech capital allocation strategies.

Stakeholder Impact

• Shareholders face increased capital risk due to the large cash outlay.
• Creditors may be impacted by the change in liquidity profile.

Next Steps

• Negotiation and execution of definitive transaction documents.
• Filing of the full term sheet as an exhibit to the Q2 2026 Form 10-Q.
• Completion of multiple cash payment closings by December 31, 2026.

Key Dates

Recommendation

Investors should adopt a wait-and-see approach until definitive agreements are signed and the company clarifies how this $120 million investment will be funded without compromising core operations.

Keywords

Scilex Holding, Datavault AI, GPU infrastructure, revenue participation, quantum-ready, capital investment